![]() ![]() Arias-Leal and Garcia-Martinez are recipients of a technician contract from “REEM: Red Española de Esclerosis Múltiple” (RETICS-REEM RD12/0032/0001 This work was financially supported by grants from the Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder) (FIS PI12/02349), “Fundación Mutua Madrileña”, and “Fundación LAIR”. Requests for the data may be sent to the corresponding author.įunding: Roberto Alvarez-Lafuente is recipient of a research contract of the Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder) (CP07/00273). The data set is not suitable for public deposition as it contains clinical patient information. ![]() This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.ĭata Availability: The authors confirm that, for approved reasons, some access restrictions apply to the data underlying the findings. Received: ApAccepted: JPublished: August 11, 2014Ĭopyright: © 2014 Ortega-Madueño et al. PLoS ONE 9(8):Įditor: Steven Jacobson, National Institutes of Health, United States of America (2014) Anti-Human Herpesvirus 6A/B IgG Correlates with Relapses and Progression in Multiple Sclerosis. Citation: Ortega-Madueño I, Garcia-Montojo M, Dominguez-Mozo MI, Garcia-Martinez A, Arias-Leal AM, Casanova I, et al. ![]()
0 Comments
Leave a Reply. |